There is a significant gap between the physician’s goal of sending patients for colorectal cancer screening, and the patient's desire to avoid complicated or cumbersome screening regimens. ColonSentry™ will help to address this gap. The test is a revolutionary advance with the potential to increase the detection of colorectal cancer 3-fold over existing practices through better patient compliance and better allocation of scarce colonoscopy resources.
ColonSentry makes testing for colorectal cancer as simple and convenient as the other blood tests performed at a patient's routine physical. The test assesses your patient’s current risk of having colorectal cancer. By adding this risk stratification tool as part of a regular health check-up, such as colonoscopy, individuals with increased risk can progress to further diagnostic testing where colorectal cancer can be identified in the early, treatable stages of the disease.
This section is designed to provide resources to help answer your questions and your patient’s questions about ColonSentry. If you have questions or would like further information on any of the reference materials discussed in these pages, we invite you to contact us at 905-739-2055 or toll-free at 1-877-GENENEWS (1-877-436-3639). You may also contact us at:
colonsentry@genenews.com